Gene | Disease | Score gda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
0.110 | GeneticVariation | BEFREE | The best predictive parameters for a NSD1 gene alteration were frontal bossing, down-slanted palpebral fissures, pointed chin and overgrowth. | 15452385 | 2004 |
||||||||
|
|
0.110 | Biomarker | HPO | |||||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Further expanding the mutational spectrum and investigation of genotype-phenotype correlation in 3M syndrome. | 30980518 | 2019 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Further expanding the mutational spectrum and investigation of genotype-phenotype correlation in 3M syndrome. | 30980518 | 2019 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Pathogenic homozygous variations in ACTL6B cause DECAM syndrome: Developmental delay, Epileptic encephalopathy, Cerebral Atrophy, and abnormal Myelination. | 31134736 | 2019 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Further expanding the mutational spectrum and investigation of genotype-phenotype correlation in 3M syndrome. | 30980518 | 2019 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations. | 28288113 | 2017 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | NAD Deficiency, Congenital Malformations, and Niacin Supplementation. | 28792876 | 2017 |
||||||||
|
|
0.100 | GeneticVariation | CLINVAR | Novel mutation in CNTNAP1 results in congenital hypomyelinating neuropathy. | 27668699 | 2017 |
||||||||
|
|
0.100 | CausalMutation | CLINVAR | De Novo GMNN Mutations Cause Autosomal-Dominant Primordial Dwarfism Associated with Meier-Gorlin Syndrome. | 26637980 | 2015 |
||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO | |||||||||||
|
|
0.100 | Biomarker | HPO |